| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | https://www.walparnutritions.com/ | |
| Market Cap | 56.34 Cr. | |
| Enterprise Value(EV) | 58.08 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 1.26 | Trailing Twelve Months Ending 2023-03 |
| Price-Earning Ratio (PE) | 95.46 | Trailing Twelve Months Ending 2023-03 |
| Industry PE | 41.01 | Trailing Twelve Months Ending 2023-03 |
| Book Value / Share | 26.84 | Trailing Twelve Months Ending 2023-03 |
| Price to Book Value | 4.47 | Calculated using Price: 120.00 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 0.47 Cr. | 4,695,220 Shares |
| FaceValue | 10 | |
| About Walpar Nutritions Ltd. | ||
| The company does third party manufacturing of Nutraceutical products on job work basis. The raw material is procured by it for which it receives order for manufacturing their semi-finished/finished Nutraceutical products. It also does marketing of products which are manufactured by it under its own brand. Its products are sold through whole seller distributors/ sales distribution channels. It is also engage in trading of raw material used in manufacturing Nutraceutical products. Such raw material is basically also raw material which is used in manufacturing of its own products. | ||
| 1 Day |
|
|
| 1 Week |
|
+9.09% |
| 1 Month |
|
-1.64% |
| 3 Month |
|
+4.35% |
| 6 Month |
|
+37.93% |
| 1 Year |
|
+92.46% |
| 2 Year |
|
+351.13% |
| 5 Year |
|
|
| 10 Year |
|
| 3 years | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 3.28 | 4.58 | 7.15 | |
| Return on Capital Employed (%) | 2.83 | 5 | 9.48 | |
| Return on Assets (%) | 0.83 | 1.55 | 2.61 |
| Particulars | 4 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 5 | 11 | 12 | 13 | |
| Non Curr. Liab. | 5 | 1 | 6 | 4 | |
| Curr. Liab. | 9 | 14 | 15 | 22 | |
| Minority Int. | 0 | 2 | 2 | 2 | |
| Equity & Liab. | 18 | 28 | 34 | 41 | |
| Non Curr. Assets | 3 | 9 | 11 | 12 | |
| Curr. Assets | 15 | 19 | 24 | 29 | |
| Misc. Exp. not W/O | 0 | 0 | 0 | ||
| Total Assets | 18 | 28 | 34 | 41 |
| Particulars | 3 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Net Sales | 6 | 27 | 35 | |
| Other Income | 0 | 0 | ||
| Total Income | 6 | 27 | 35 | |
| Total Expenditure | -6 | -26 | -32 | |
| PBIDT | 0 | 1 | 4 | |
| Interest | 0 | 0 | -1 | |
| Depreciation | 0 | 0 | -2 | |
| Taxation | 0 | 0 | 0 | |
| Exceptional Items | ||||
| PAT | 0 | 0 | 1 | |
| Minority Interest | 0 | 0 | ||
| Share Associate | ||||
| Other Related Items | ||||
| Consolidated Net Profit | 0 | 0 | 1 | |
| Adjusted EPS | 0 | 1 | 1 |
| Particulars | 3 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | -1 | 1 | |
| Cash Fr. Inv. | -2 | -6 | -3 | |
| Cash Fr. Finan. | 3 | 7 | 2 | |
| Net Change | 1 | -1 | 0 | |
| Cash & Cash Eqvt | 1 | 0 | 1 |
|
Mon, 15 Apr 2024
Updates Walpar Nutritions Limited has informed the Exchange regarding 'Non-applicability of Corporate Governance Provisions as per SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015'. |
|
Mon, 15 Apr 2024
Updates Walpar Nutritions Limited has informed the Exchange regarding 'Submission of Certificate under Regulation 74(5) of SEBI (Depository and Participant) Regulation, 2018 for the Quarter ended on 31st March, 2024'. |
|
Sat, 30 Mar 2024
Trading Window Walpar Nutritions Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| Mon, 15 Apr 2024 |
Opening at High
|
Opening at Low
|
Opening at Low for 3 days
|
Closing Above Previous High
|
Opening at Low for 2 Days
|
